ArticlePharmacological research2016

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Nadiya Druzhyna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.